Shenwan Hongyuan (SWHY) healthcare team reiterated its positive recommendation on Furei Medical (300049) on October 8, 2026, citing continued MASH industry momentum and a series of upcoming catalysts.
SWHY remains bullish on Furei Medical, viewing the recent correction as a buying opportunity ahead of multiple near-term catalysts.
Free preview — more China A-share & HK research · About Us · Legal & Privacy